Celecoxib Impurity 2

Celecoxib Impurity 2 is a tricyclic pyrazole derivative featuring a 4-fluorophenyl substituent, a 5-methylpyrazole ring, and a trifluoromethyl group. It lacks the sulfonamide moiety present in Celecoxib, instead retaining a methylated nitrogen at the pyrazole core. This structural divergence arises from an incomplete sulfonation step during Celecoxib synthesis, resulting in a stable, low-polarity byproduct. The compound exhibits elevated thermal stability due to trifluoromethyl conjugation and serves as a critical HPLC reference standard for monitoring synthetic pathway fidelity and impurity profiling in API development.